Uncategorized

Follow the Occam blog for insights from our team, news on recent placements, and our thoughts on how to stay a cut above in executive recruiting and organizational management.

Occam Places Jorge Bartolome as CEO at Areteia Therapeutics

Read Story

Occam Recruits Michael Miller to the Board of BioXcel

Read Story

Occam Places Dan Marquess as CSO at Vicinitas Therapeutics

Read Story

Occam Places Paul Thibodeau as CBO of Hotspot

Read Story

Occam Places Amber Salzman as CEO of Epic Bio

Read Story

Occam Places Colin McCracken as Chief Executive Officer at Evonetix

Read Story

Occam Places Gary Glick as Chairman at CHARM Therapeutics

Read Story

Occam Places Juan Estupinan as Chief Financial Officer at Vestaron

Read Story

Occam Places Ryan Kelly as Chief Communications Officer at Recursion

Read Story

Occam Places Kali Stasi as SVP Clinical Development at Tenpoint Therapeutics

Read Story

Occam Places Rabia Gurses Ozden as Board Member at Adverum

Read Story

Occam Places Craig Thompson as CEO at Cerevance

Read Story

Occam Places Wendy Young as Executive Partner at MPM Capital

Read Story

Occam Places Jim Wang as SVP, Regulatory Affairs at Adverum

Read Story

Occam Places Louisa Daniels as General Counsel at Recursion

Read Story

Occam Client and Alvin Shih Led Disarm Therapeutics to be Acquired By Eli Lilly

Read Story

Occam Client and Ted Ashburn Led Oncorus Launches IPO

Read Story

Emly Conley secures $50M in financing to advance Federation Bio’s microbial platform

Read Story

BlackRock Leads $50 Million Round in Hydropanel Startup Zero Mass Water

Read Story

Occam Remains Alive and Well in the Time of COVID

Read Story

Occam client Accent Therapeutics forms cancer therapeutics collaboration with AstraZeneca

Read Story

Variant Bio Aims to Make Use of Humanity’s Genetic Outliers

Read Story

Generation Bio tees up $125M IPO to push next-gen gene therapies

Read Story